Photobiomodulation in plain English. How specific wavelengths of red and near-infrared light reach your mitochondria, what they actually do once they're there, and what 6,000+ peer-reviewed studies have measured.
Red and near-infrared light at 660 nm and 850 nm are absorbed by mitochondria in your skin cells. This boosts ATP production, reduces oxidative stress, and accelerates collagen synthesis. The effect is measurable, dose-dependent, and well-studied — but only at clinical wavelengths and irradiance.
Photobiomodulation (PBM) — formerly called low-level laser therapy (LLLT) or cold laser — is the use of specific wavelengths of red and near-infrared light to elicit a measurable biological response in living tissue.
It is non-thermal (your skin doesn't heat up), non-ionizing (unlike UV, it doesn't damage DNA), and non-ablative (it doesn't break or wound the skin like a laser resurfacing treatment would).
Light at these wavelengths penetrates the skin and is absorbed by chromophores — molecules in your cells that respond to specific colors of light. The primary chromophore for PBM is cytochrome c oxidase, an enzyme embedded in the inner membrane of your mitochondria.
When light is absorbed there, a cascade of secondary effects follows: increased ATP synthesis, modulated reactive oxygen species, released nitric oxide. The net result is faster cellular repair, more collagen production, and reduced inflammation.
The visible light spectrum spans roughly 380 to 700 nanometers. Beyond 700 nm, light becomes invisible to the human eye — that's the near-infrared (NIR) range. Two narrow bands within this spectrum are responsible for the photobiomodulation effect: 630–680 nm (red) and 800–880 nm (near-infrared). Anything outside these windows produces little to no measurable biological response.
Most clinical research uses both wavelengths together — a "dual-chip" delivery — because the two penetrate to different tissue depths and trigger complementary responses. Single-wavelength devices (especially cheap consumer panels that only emit 630 nm) deliver a fraction of the biological effect.
The mechanism has been mapped at the molecular level. It happens in three sequential stages, all within minutes of light exposure.
Photons at 660 nm and 850 nm pass through skin tissue and are absorbed by cytochrome c oxidase (CCO) — the terminal enzyme in the mitochondrial respiratory chain.
Light absorption knocks nitric oxide loose from CCO's active site. NO had been inhibiting oxygen binding — its release restores normal electron transport.
With electron transport restored, ATP synthesis increases. Cells now have the energy budget for collagen production, repair, and inflammation control.
Twice-weekly 660/850 nm sessions over 30 weeks produced significant improvement in skin complexion, feeling, intradermal collagen density, and reduction in fine lines.
Comprehensive review establishing cytochrome c oxidase as the primary photoacceptor and mapping the downstream signaling pathways: NO release, mitochondrial membrane potential, ATP synthesis.
8 sessions over 4 weeks using 633 + 830 nm LEDs delivered measurable reduction in wrinkle depth, with sustained improvement at 12-week follow-up.
This is a curated selection. The full research bibliography — 240+ studies organized by indication — is available on request.
Photobiomodulation follows a biphasic dose response: too little light produces no effect, the right dose produces maximum effect, and more than that actually diminishes the response. Doubling your session time will not double your results — it can reduce them.
The therapeutic dose is determined by three variables: wavelength, irradiance (intensity at the skin), and time. Together these give you the fluence — measured in joules per square centimeter. Clinical studies converge on a window of 4–60 J/cm² per session.
For at-home eye-area devices, this translates to 8–12 minutes per session at a recommended contact distance.
The use of specific wavelengths of light to elicit a non-thermal biological response in living tissue. Abbreviated PBM. Encompasses what used to be called LLLT (low-level laser therapy) and cold laser.
The terminal enzyme in the mitochondrial electron transport chain, and the primary photoacceptor for red and near-infrared light. Often abbreviated CCO or Complex IV.
The power of light arriving at a target surface, measured in milliwatts per square centimeter (mW/cm²). Higher irradiance delivers the same dose in less time.
Total light energy delivered to a target surface, measured in joules per square centimeter (J/cm²). Fluence = irradiance × time. The "dose" of a session.
A response curve where small and large doses both produce less effect than the optimal mid-range dose. Characteristic of photobiomodulation: more is not better past the peak.
The primary energy-carrying molecule used by living cells for nearly every process — including DNA synthesis, muscle contraction, and the repair of damaged tissue.
Every RayAid device is built around the dosing windows you just read about — clinical wavelengths, calibrated irradiance, auto-shutoff at the dose ceiling. So you don't have to think about any of it.
Shop devices